Search results for "iNOS"

showing 10 items of 2075 documents

Combination of aztreonam, ceftazidime–avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis

2021

Abstract We describe a challenging case of patient with metallo-beta-lactamase-producing Pseudomonas aeruginosa sternal osteomyelitis following aortic valve replacement with biological prosthesis. The strain exhibited a multidrug-resistance phenotype carrying the blaVIM-1 gene and belonged to the high-risk clone sequence type ST235. The patient was successfully treated with surgical debridement plus antibiotic therapy with ceftazidime/avibactam, aztreonam, and amikacin. Time-kill curves showed that this triple antibiotic combination at 1 × MIC was strongly synergic after 8 h, achieving 99.9% killing and maintaining this until 48 h.

Microbiology (medical)AvibactamDrug ResistanceCeftazidimeInfectious and parasitic diseasesRC109-216Aztreonammedicine.disease_causeST235CeftazidimeMicrobiologyCeftazidime–avibactamchemistry.chemical_compoundAztreonamAortic valve replacementDrug TherapyDrug Resistance Multiple BacterialmedicineHumansPseudomonas InfectionsPseudomonas aeruginosa; ST235; VIM-1; aztreonam; ceftazidime-avibactam; osteomyelitisAmikacinAgedPseudomonas aeruginosabusiness.industryceftazidime-avibactamOsteomyelitisBacterialOsteomyelitisGeneral MedicineCeftazidime/avibactammedicine.diseaseAnti-Bacterial AgentsDrug CombinationsInfectious DiseaseschemistryDebridementAmikacinPseudomonas aeruginosaCombinationVIM-1Drug Therapy CombinationFemalebusinessAzabicyclo CompoundsMultiplemedicine.drug
researchProduct

Evaluation of the in-vitro cidal activity and toxicity of a novel peroxygen biocide: 2-butanone peroxide

2007

The monomer of 2-butanone peroxide is a novel peroxygen derivative with potential use as biocide in the hospital environment. The aim of this study was to test the biocidal activity of different concentrations of the compound against American Tissue Culture Collection strains from 11 different micro-organisms, including bacteria, mycobacteria, spores, fungi and virus, following the European Standard guidelines. Toxicity tests were also carried out following United States Environmental Protection Agency Standards. 2-Butanone peroxide exhibited biocidal activity at 0.12% against Legionella pneumophila, at 0.5% against Escherichia coli, Pseudomonas aeruginosa and Enterococcus hirae, and at 1% …

Microbiology (medical)BiocideMicrococcaceaeGuinea PigsGram-Positive Bacteriamedicine.disease_causePeroxideMicrobiologychemistry.chemical_compoundEnterococcus hiraeGram-Negative BacteriaToxicity TestsAnimalsMedicinebiologybusiness.industryPseudomonas aeruginosaBiological activityGeneral Medicinebiology.organism_classificationButanonesPeroxidesInfectious DiseaseschemistryStaphylococcus aureusToxicityRabbitsbusinessDisinfectantsJournal of Hospital Infection
researchProduct

Sepsis due to Erysipelothrix rhusiopathiae in a Patient with Chronic Lymphocytic Leukemia Associated with Bronchopneumonia due to PSeudomonas aerugin…

2015

Erysipelothrix rhusiopathiae infections can typically be attributed to exposure to animal products; thus, these infections are more common among farmers, butchers and veterinarians, among others. This article describes a case involving a 54-year-old man who had relative neutropenia subsequent to treatment for chronic lymphocytic leukemia. The patient developed E rhusiopathiae bacteremia with concomitant pneumonia. The author of this article suggests a likely route of infection, which is atypical considering the patient did not report exposure to animal products.

Microbiology (medical)Chronic lymphocytic leukemiaCase ReportBronchopneumoniaANIMAL EXPOSUREInfectious and parasitic diseasesRC109-216Erysipelothrix rhusiopathiaemedicine.disease_causeMicrobiologyMicrobiologySepsisSepsisMedicineEscherichia coliImmunocompromised hostbiologyErysipelothrix rhusiopathiaebusiness.industryPseudomonas aeruginosabiology.organism_classificationmedicine.diseaseQR1-502Infectious DiseasesConcomitantImmunologybusinessCanadian Journal of Infectious Diseases and Medical Microbiology
researchProduct

La protección internacional de zonas y especies en la región mediterránea

2018

INTRODUCCIÓN.- PARTE PRIMERA: ZONAS Y ESPECIES PROTEGIDAS INTERNACIONALMENTE EN LA REGION MEDITERRÁNEA. I. LAS ZONAS ESPECIALMENTE PROTEGIDAS Y LA PROTECCIÓN DE LAS ESPECIES EN EL DERECHO INTERNACIONAL. 1. El planteamiento aislante. 2. El planteamiento comprehensivo. a) Los tratados pioneros. b) De la Declaración de Estocolmo en adelante. 3. Hacia la utilización sostenible. II. LAS ZONAS ESPECIALMENTE PROTEGIDAS y LA PROTECCIÓN DE LAS ESPECIES EN EL MEDITERRÁNEO. 1. El antiguo marco para la protección del Mar Mediterráneo contra la contaminación. 2. El período de transición. 3. El nuevo marco para la protección del medio marino y de la región costera del Mediterráneo. PARTE SEGUNDA: LA REGL…

Microbiology (medical)Dret internacionalImmunologyConservación de los recursos marinosImmunology and AllergyMedi ambient ProteccióZonas protegidasEspecies protegidasReglamentación internacional de la pescaPesqueríasMediterráneoFauna ProteccióDerecho del mar
researchProduct

New β-Lactam-β-Lactamase Inhibitor Combinations.

2020

The limited armamentarium against drug-resistant Gram-negative bacilli has led to the development of several novel β-lactam-β-lactamase inhibitor combinations (BLBLIs). In this review, we summarize their spectrum of in vitro activities, mechanisms of resistance, and pharmacokinetic-pharmacodynamic (PK-PD) characteristics. A summary of available clinical data is provided per drug. Four approved BLBLIs are discussed in detail. All are options for treating multidrug-resistant (MDR) Enterobacterales and Pseudomonas aeruginosa Ceftazidime-avibactam is a potential drug for treating Enterobacterales producing extended-spectrum β-lactamase (ESBL), Klebsiella pneumoniae carbapenemase (KPC), AmpC, an…

Microbiology (medical)DrugImipenemBacilliEpidemiologyKlebsiella pneumoniaemedia_common.quotation_subjectMicrobial Sensitivity Testsmedicine.disease_causebeta-LactamsMeropenemMicrobiologyDrug Resistance Multiple BacterialGram-Negative Bacteriapolycyclic compoundsmedicinemedia_commonGeneral Immunology and MicrobiologybiologyPseudomonas aeruginosabusiness.industryPublic Health Environmental and Occupational Healthbiochemical phenomena metabolism and nutritionbacterial infections and mycosesbiology.organism_classificationCeftazidime/avibactamAcinetobacter baumanniiDrug CombinationsInfectious DiseasesbacteriaErratumbusinessbeta-Lactamase Inhibitorsmedicine.drugClinical microbiology reviews
researchProduct

La protección de los mamíferos marinos en el mar Mediterráneo

2018

El presente artículo analiza los instrumentos jurídicos internacionales adoptados para la protección de los mamíferos marinos en el Mar Mediterráneo. Los Estados ribereños de este Mar han preferido impulsar una fuerte colaboración regional a este respecto, en lugar de proceder a una ratificación sistemática de los tratados internacionales ambientales de ámbito mundial. Se analizan tres desarrollos regionales importantes. En primer lugar, en el marco de la cooperación regional marina propiciada por el PNUMA, los instrumentos jurídicos adoptados en desarrollo del Convenio de Barcelona para la protección del medio marino mediterráneo. En segundo lugar, el Acuerdo sobre la conservación de los c…

Microbiology (medical)Fauna marinaDret internacionalImmunologyProtecciónImmunology and AllergyEspécies en peligroMediterráneoDerecho del marFauna ProteccióMamíferos marinosAnuario Español de Derecho Internacional
researchProduct

The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity

2013

AbstractCoeliac disease is characterized by intestinal inflammation caused by gluten, proteins which are widely contained in the Western diet. Mammalian digestive enzymes are only partly capable of cleaving gluten, and fragments remain that induce toxic responses in patients with coeliac disease. We found that the oral microbiome is a novel and rich source of gluten-degrading organisms. Here we report on the isolation and characterization of the cultivable resident oral microbes that are capable of cleaving gluten, with special emphasis on the immunogenic domains. Bacteria were obtained by a selective culturing approach and enzyme activities were characterized by: (i) hydrolysis of paranitr…

Microbiology (medical)GlutensDental Plaquemedicine.disease_causeCoeliac diseaseArticleMicrobiologyoral bacteriaStreptococcus mitismedicineActinomycesHumansSalivadegradationchemistry.chemical_classificationbiologyBacteriaCoeliac diseaseMicrobiotaRothia aeriaNeisseria mucosaStreptococcusnutritional and metabolic diseasesGeneral Medicinebiology.organism_classificationmedicine.diseaseCapnocytophagaGlutendigestive system diseasesCeliac DiseaseInfectious DiseaseschemistryBiochemistrybiology.proteingliadinproteasesGliadinRothia mucilaginosaCapnocytophagaActinomycesClinical Microbiology and Infection
researchProduct

On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy

2015

Bacteriophages are bacterial viruses, capable of killing even multi-drug resistant bacterial cells. For this reason, therapeutic use of phages is considered as a possible alternative to conventional antibiotics. However, phages are very host specific in comparison to wide-spectrum antibiotics and thus preparation of phage-cocktails beforehand against pathogens can be difficult. In this study, we evaluate whether it may be possible to isolate phages on-demand from environmental reservoir. We attempted to enrich infectious bacteriophages from sewage against nosocomial drug-resistant bacterial strains of different medically important species in order to evaluate the probability of discovering …

Microbiology (medical)Phage cocktailsantibiotic resistancephage therapyPhage therapyKlebsiella pneumoniaevirusesmedicine.medical_treatmentlcsh:QR1-502MRSABiologyta3111medicine.disease_causeMicrobiologybakteriofagitlcsh:MicrobiologyMicrobiologyAntibiotic resistancephage cocktailsmedicineBacteriophagesVancomycin-resistant EnterococcusOriginal ResearchPseudomonas aeruginosata1183biology.organism_classificationVirologyMethicillin-resistant Staphylococcus aureusfagiterapia3. Good healthAcinetobacter baumanniiESBLBacterial virusantibioottiresistenssiFrontiers in Microbiology
researchProduct

Class 1 integrons in environmental and clinical isolates of Pseudomonas aeruginosa.

2011

The aims of this study were to ascertain the presence and spread of class 1 integrons amongst environmental and clinical isolates of Pseudomonas aeruginosa and to characterise their variable regions. A total of 76 isolates (56 clinical and 20 environmental) were studied. The presence of plasmids was explored, and polymerase chain reaction (PCR) was used for integron detection. All amplicons were sequenced. PCR detected class 1 integrons in 26 of the 56 clinical isolates; environmental isolates were integron-free. No plasmids were found, thus all the integrons found are possibly on the chromosome. Most isolates presented one amplicon, except PA110514 and PA116136, which showed two PCR produc…

Microbiology (medical)Transposable elementDNA BacterialMicrobial Sensitivity TestsBiologymedicine.disease_causeIntegronPolymerase Chain Reactionlaw.inventionMicrobiologyIntegronsPlasmidAntibiotic resistancelawDrug Resistance Multiple BacterialmedicineHumansPharmacology (medical)Pseudomonas InfectionsPolymerase chain reactionGeneticsPseudomonas aeruginosaGeneral Medicinebiochemical phenomena metabolism and nutritionAmpliconAnti-Bacterial AgentsBacterial Typing TechniquesInfectious DiseasesFomitesHorizontal gene transferPseudomonas aeruginosabiology.proteinbacteriaWater MicrobiologyPlasmidsInternational journal of antimicrobial agents
researchProduct

Extraction, Structural Characterisation, and Immunomodulatory Properties of Edible Amanita hemibapha subspecies javanica (Corner and Bas) Mucilage Po…

2021

This research aimed to extract mucilage polysaccharides (MP) from Amanita hemibapha subspecies javanica (Corner and Bas), and further fractionate them using anion-exchange chromatography, yielding two fractions (MPF1 and MPF2). The crude extract, and fractions mainly consisted of carbohydrates (83.5–93.2%) with minor amounts of proteins (5.40–7.20%), and sulphates (1.40–9.30%). Determination of the monosaccharide composition revealed that glucose was the major unit, followed by galactose, mannose, rhamnose, and arabinose. The average molecular weight (MW) of the crude extract and fractions was in the range 104.0–479.4 × 103 g/mol. Interestingly, the crude extract, and fractions did not caus…

Microbiology (medical)chemistry.chemical_classificationArabinosebiologyQH301-705.5ChemistryRhamnoseMannosePlant ScienceFractionationbiology.organism_classificationPolysaccharideimmunomodulatory propertyfunctional foodchemistry.chemical_compound<i>Amanita hemibapha</i> subspecies <i>javanica</i> (Corner and Bas)mucilage polysaccharideMucilageAmanita hemibaphaGalactosemushroomFood sciencefractionationBiology (General)Ecology Evolution Behavior and SystematicsJournal of Fungi
researchProduct